The race to be the global leader in genetic engineering is an interesting one. It seems the Chinese government has a fail fast mentality in the field, as they have reportedly began conducting CRISPR-Cas9 tests on over 80 patients since 2015.

Although similar tests have been implemented on smaller scales in the U.S. and Europe, these countries have been extra cautious with this innovative technology.